Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

7 Dec 2022 07:00

RNS Number : 8268I
Camellia PLC
07 December 2022
 

7 December 2022

Camellia Plc

 

(the "Company" or the "Group")

 

Trading update

 

Further to the trading announcement on 22 November there has been no change to our expectations for underlying profit before tax for the Group for 2022, with the exception of the trading for BF&M Limited (BF&M) which announced Q3 results yesterday which are significantly below our expectations.

BF&M reported a shareholders' net loss of Bermuda$13.4 million for the nine months ended 30 September 2022, as compared to shareholders' net income for the comparative period in 2021 of Bermuda$19.5 million. Net income from operations after excluding the negative fair value movements in investments was Bermuda$9.3 million versus Bermuda$17.8 million in the first nine months of 2021. Despite the economic headwinds and investment market volatility that continue to impact BF&M results, BF&M's underlying business is trending favourably with Property and Casualty benefiting from a strong rate environment and minimal exposure to Hurricanes Fiona and Ian. Group Life results were strong while Group Health claims remain elevated over pre-pandemic levels. The Pension and Annuity businesses remains well-positioned to optimise opportunities as the markets settle.

Equity attributable to BF&M's shareholders at 30 September 2022 was $294.0 million.

Excluding any financial results for BF&M, the Company believes that the adjusted profit before tax* for the Group will be approximately 50 - 55% below that of last year. In light of BF&M's Q3 results, it is likely that adjusted profit before tax* for the Group for the year ended 31 December 2022 will be lower than announced on 22 November 2022. However as a consequence of the impact of the volatility of equity and bond markets on BF&M's results, it is not possible for Camellia to forecast the likely full year outcome for BF&M with any certainty.

 

* adjusted profit before tax seeks to present an indication of performance which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMGZGVZGZZZ
Date   Source Headline
29th Apr 20103:04 pmRNSAnnual Financial Report
15th Apr 20102:08 pmRNSDisposal
1st Apr 201011:10 amRNSAppointment of Joint Managing Directors
26th Mar 201010:30 amRNSDirectorate Change
25th Mar 201011:59 amRNSInterim Management Statement
8th Mar 20107:00 amRNSDisposal
5th Mar 20107:00 amRNSStatement Re Siegfried Holding AG
28th Oct 20093:20 pmRNSInterim Management Statement
13th Oct 200910:06 amRNSCircular regarding change of auditor
14th Sep 20094:00 pmRNSDisposal
8th Sep 200910:44 amRNSHalf Yearly Report
27th Aug 200911:00 amRNSHalf Yearly Report
29th Jun 20094:40 pmRNSSecond Price Monitoring Extn
29th Jun 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20094:40 pmRNSSecond Price Monitoring Extn
10th Jun 20094:35 pmRNSPrice Monitoring Extension
4th Jun 20091:40 pmRNSResult of AGM
3rd Jun 20094:40 pmRNSSecond Price Monitoring Extn
3rd Jun 20094:35 pmRNSPrice Monitoring Extension
3rd Jun 200912:12 pmRNSAGM Statement
29th May 20092:55 pmRNSAnnual Information Update
6th May 20092:00 pmRNSAnnual Report and Accounts
28th Apr 20096:26 pmRNSAnnual Financial Report
26th Mar 20092:20 pmRNSInterim Management Statement
2nd Feb 20094:35 pmRNSPrice Monitoring Extension
3rd Dec 20082:23 pmRNSDirector/PDMR Shareholding
24th Nov 20083:37 pmRNSHolding(s) in Company
21st Oct 20084:44 pmRNSSecond Price Monitoring Extn
21st Oct 20084:37 pmRNSPrice Monitoring Extension
2nd Oct 20082:30 pmRNSInterim Management Statement
29th Sep 20082:02 pmRNSDirectorate Change
17th Sep 20083:08 pmRNSInterim Report
28th Aug 20083:29 pmRNSInterim Results
6th Jun 200812:52 pmRNSResult of AGM
5th Jun 200812:13 pmRNSAGM Statement
30th May 20082:41 pmRNSAnnual Information Update
21st May 200811:49 amRNSDirector/PDMR Shareholding
13th May 20083:41 pmRNSDirector/PDMR Shareholding
8th May 20084:04 pmRNSDirector/PDMR Shareholding
2nd May 200812:19 pmRNSAnnual Report and Accounts
29th Apr 20084:12 pmRNSDirector/PDMR Shareholding
24th Apr 200812:35 pmRNSPreliminary announcement
27th Mar 20083:09 pmRNSInterim Management Statement
4th Oct 20073:16 pmRNSInterim Report
27th Sep 200712:30 pmRNSInterim Results
9th Aug 20074:24 pmRNSHolding(s) in Company
8th Jun 20074:06 pmRNSResult of AGM
7th Jun 200712:15 pmRNSAGM Statement
1st Jun 20073:01 pmRNSAnnual Information Update
4th May 20079:39 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.